This week Gavi, the Vaccine Alliance announced a decision to support humanitarian organisations working in Syria to prevent outbreaks of preventable diseases amid the conflict.

Immunisation in Côte d’Ivoire took centre stage as, five years after civil war, they reported vaccination progress and politicians explained their dedication to the cause.

MERS vaccine research got funded, and journalists considered how a Zika vaccine might be brought to market once it gets approved. As discussions continued around the utility of the current dengue vaccine, a US team began exploring another type of vaccine against the disease.